17.70USD-4.56%Mkt Cap: 669.69M USDP/E: —Last update: 2026-06-01
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the ac…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap669.69M USD
Enterprise Value580.97M USD
Revenue (TTM)95.07M USD
Gross Profit78.27M USD
Net Income (TTM)-53.41M USD
Revenue/Share2.570 USD
Last Price17.70 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees327
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.80
PEG—
EV/EBITDA-9.12
EV/Revenue6.11
P/S7.36
P/B4.96
EPS (TTM)-1.62
EPS (Forward)-1.10
52W Range
10.8551% of range24.33
52W High24.33 USD
52W Low10.85 USD
Profitability
Gross Margin87.89%
Oper. Margin-78.30%
EBITDA Margin-67.00%
Profit Margin-59.97%
ROE-34.38%
ROA-27.28%
Growth
Revenue Growth29.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-40.81M USD
CapEx (TTM)767.00K USD
FCF Margin-30.86%
FCF Yield-4.38%
Net Debt-119.07M USD
Net Debt/EBITDA1.87
Balance Sheet
Debt/Equity0.14
Current Ratio10.44
Quick Ratio9.70
Book Value/Sh3.719 USD
Cash/Share3.721 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)26.86 USD
Target Range24.00 USD – 32.00 USD
# Analysts7
Ownership
Shares Out.37.94M
Float26.19M
Insiders12.76%
Institutions86.75%
Short Interest
Short Ratio6.2d
Short % Float7.98%
Short % Out.5.17%
Shares Short1.96M
Short (prev mo.)1.53M
Technical
SMA 5019.13 (-7.5%)
SMA 20017.02 (+4.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)297.32K
Avg Vol (10d)307.62K
Technical Indicators
RSI (14)48.1
MACD-0.2991
MACD Signal-0.4001
MACD Hist.+0.1010
BB Upper21.59 USD
BB Middle18.66 USD
BB Lower15.74 USD
BB Width31.35%
ATR (14)0.8805 USD
Vol Ratio (20d)0.17x